Bone Markers

Saturday, May 24 2008

Biographies

Luisa Alvarez

Luisa Alvarez PhD. Senior Consultant, Biochemistry and Molecular Genetics Service. Quality Director of Biomedical Diagnosis Centre of Hospital Clinic. Barcelona. Researcher of Metabolic Bone Pathology Unit of “Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS)”. Barcelona. Spain.
She studied Pharmacy at the University of Barcelona and worked from 1974 to 1900 as Assistant in Clinical Biochemistry at Sant Joan de Deu Hospital, Barcelona. From 1977 to 1979 she was Associated Professor in Biochemistry in the School of Pharmacy, University of Barcelona, and between 1991 and 2004 Collaborative Proffesor in Biochemistry and Clinical Biochemistry at the School of Medicine, University of Barcelona.
Her research interests included utility of bone turnover markers and Paget bone disease. She has published several articles on bone turnover markers and related topics.

Pierre D Delmas

Dr Delmas is professor of medicine and rheumatology at the Université Claude Bernard, in Lyon, France. He serves as chairman of the department of rheumatology at the Hôpital Edouard Herriot, also in Lyon. He is the director of Research Unit 831 on Pathophysiology of Osteoporosis, an arm of the French National Institute for Medical Research (INSERM).

Dr Delmas earned his MD from the Claude Bernard University of Lyon in 1975, his MS from the same university in 1980, and his PhD in human biology-biochemistry in 1984. He performed research at the Mayo Clinic in Rochester, Minnesota, in 1981 and 1982, working in the departments of endocrinology and biochemistry.

Dr Delmas is president of the board of the International Osteoporosis Foundation (IOF), general Secretary of the European Society for Clinical and Economic aspects of osteoporosis and osteoarthritis (ESCEO) and chairman of the Health Council on Osteoporosis. He is also an active member of the American Society for Bone and Mineral Research (ASBMR). He is the recipient of the André Lichtwitz Prize, the Prize of the Fondation Nationale de la Recherche Médicale, the Philippe Bordier Prize, and the prize of the Institute for Scientific Information (ISI) given in 2001 for the most cited French scientists. In 2004, he received the Frederic C. Bartter Award given by the ASBMR for outstanding clinical investigation in disorders of bone and mineral metabolism.

Among his research initiatives, Dr Delmas and his group at INSERM have developed new markers of bone, cartilage and synovium metabolism, such as osteocalcin and pyridinoline crosslinks, that have been shown to be useful in the clinical investigation of metabolic bone diseases and arthritis. He directs basic and clinical research programs in metabolic bone diseases, with a special interest in osteoporosis and osteoarthritis. His research interests also include the study of osteoarthritis. Dr. Delmas has authored more than 400 articles, reviews, and chapters in a variety of international scientific journals and textbooks. His role as president of the IOF board includes the development of educational programs on osteoporosis.

Dr Delmas is editor in chief of Osteoporosis International. He has also served as Associate Editor of Bone and on the editorial boards of Drugs and Aging, European Journal of Experimental Musculoskeletal Research, Journal of Bone and Mineral Research, and Calcified Tissue International.

David Dempster

Dr Dempster is a Professor of Clinical Pathology at Columbia University in New York and the Director of the Regional Bone Center at the Helen Hayes Hospital in West Haverstraw, New York. Dr Dempster obtained his PhD from the University of Glasgow, and completed postdoctoral studies in Switzerland and France. He has published over 150 research papers on the pathophysiology and treatment of bone disease. He is a Fellow of the Royal Microscopical Society and an active member of the American Society for Bone and Mineral Research, the Endocrine Society, and was a founding member of the International Society of Musculoskeletal and Neuronal Interactions. Dr Dempster was President of the International Society of Bone Morphometry from 1996 to 1999, and serves on the Scientific Advisory Council of the National Osteoporosis Foundation. Dr Dempster is an Associate Editor of Osteoporosis International, and has served on the Editorial Boards of Endocrinology and the Journal of Bone and Mineral Research. He is currently a member of the Editorial Boards of Bone and The Journal of Clinical Densitometry.

Richard Eastell

Professor Eastell is Professor of Bone Metabolism at the University. He is an Honorary Consultant Physician in metabolic bone disease at the Northern General Hospital, Sheffield. He qualified in medicine from Edinburgh in 1977. He trained at the Mayo Clinic under Dr B L Riggs for 5 years. He became a fellow of the Royal College of Physicians of London in 1996, an honorary fellow of the Royal College of Physicians of Ireland in 1998 and a Fellow of the Royal College of Physicians of Edinburgh, the Royal College of Pathology and the Academy of Medical Sciences in 2000.

He is the head of the Academic Unit of Bone Metabolism Group and has an active research group into the pathophysiology, diagnosis and treatment of osteoporosis. He has published over 200 papers on osteoporosis and related topics. In 1997, he was awarded Hospital Doctor of the Year in the osteoporosis category, in 1998 he was awarded the Corrigan Medal of the Royal College of Physicians of Ireland, and in 2003, was part of the team awarded the Queen’s Anniversary Award to the University of Sheffield for the Health and Social Care of Older People. In 2004, he was awarded the Kohn Foundation award from the National Osteoporosis Society and the Society of Endocrinology Medal. He is on the editorial board of Osteoporosis International, Osteoporosis Review, and Journal of Clinical Endocrinology and Metabolism. He is the Past President of the UK Bone Research Society and the President of the European Calcified Tissue Society. He is Chairman of the National Osteoporosis Society.

Patrick Garnero

Patrick Garnero, Ph.D. is senior scientist at the French National Institute for Health and Medical Research (INSERM, Unit 664) and Vice-President of the Biochemical Markers Division of Synarc in Lyon, France.

Dr. Garnero received a Ph.D. in Human Biology and Biochemistry from the University of Lyon, France in the research group of Pierre D. Delmas, MD, Ph.D. He was visiting scientist in the Center for Clinical and Basic Research in Copenhagen, Denmark (CCBR, Dr Christiansen).

Dr Garnero is an active researcher in the field of metabolic bone diseases with special focus on osteoporosis, osteoarthritis and metastatic bone diseases. He is an internationally-recognized leader in the field of bone and cartilage biochemical markers.

Dr Garnero authored more than 200 articles and book chapters in international scientific journals. He is advisory editor of Arthritis and Rheumatism and member of the editorial boards of Bone and
Osteoporosis International. He serves on standardization committees and expert panels under the auspices of the US National Institutes of Health (NHI) and the Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) to advance biochemical markers in clinical research.

Nuria Guañabens

Education/Training/ Positions: Residency in Internal Medicine and Rheumatology, Hospital Clinic, Barcelona. Senior Consultant Physician, and Chief of the Department of Rheumatology, Hospital Clinic, Barcelona. Spain.

Professional Societies: President of the Spanish Society for Bone and Mineral Research (2003-2007), Treasurer of the Spanish Society for Bone and Mineral Research (1999-2003), Board member of the Catalan Society of Rheumatology (1995-1997) and the Spanish Society of Rheumatology (2000-2004).

Publications: More than 150 publications including original articles, reviews, editorials and book chapters.

Fields of interest: Bone markers; bone disease associated with liver diseases and liver transplantation; male osteoporosis; Paget’s disease; bone cell cultures (primary osteoblasts).

Christian Meier

Dr. Christian Meier is a consultant at the Division of Endocrinology, Diabetes and Clinical Nutrition at University Hospital Basel, Switzerland. Christian received his scientific and medical training (Swiss Board Certification in Internal Medicine 1997 and in Endocrinology & Diabetology 1999) in Switzerland and in Australia. From 2002-2004, he joined the Bone Biology Research Group at the ANZAC Research Institute in Sydney (headed by Prof. Markus J. Seibel) and was involved in various clinical projects assessing the clinical utility of bone turnover markers. His research interests include various aspects of bone and mineral metabolism, specifically pathophysiological aspects of male osteoporosis and male aging.
He is an author on more than 100 scientific contributions and currently is a member of the editorial board of the Journal of Bone and Mineral Research.

Ana Monegal

M.D., Ph.D. Specialist in Rheumatology. Department of Rheumatology, Member of the Metabolic Bone Diseases Unit. Hospital Clinic, Barcelona, Spain.

Publications: More than 70 publications including original articles, reviews, editorials and book chapters and 185 communications to national and international congresses.

Young Investigator Award: 1996 World Congress on Osteoporosis.

Fields of interest: Bone markers; bone disease associated with liver and kidney transplantation; male osteoporosis; Paget’s disease.

Pilar Peris

M.D., PhD, specialist in Rheumatology working at the Rheumatology Service of the Hospital Clinic, University of Barcelona. Member of the Metabolic Bone Diseases Unit of this Hospital and researcher of the IDIBAPS (Institut de Investigacions Biomediques August Pi I Sunyer). Member of various National and International medical societies.
Publications: 107 national and international articles (including originals, clinical reports, letters, editorials and reviews), 25 chapters of books and in 215 communications to national and international congresses.
Fields of interest: Bone markers, Paget’s disease, male osteoporosis, premenopausal osteoporosis, bone disease associated with liver disease and liver transplantation, alcohol and bone.